Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $11.35, for a total value of $340,500.00. Following the sale, the insider now directly owns 1,696,097 shares in the company, valued at approximately $19,250,700.95. The trade was a 1.74 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, October 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.77, for a total transaction of $323,100.00.
• On Thursday, August 22nd, Dawn Christine Maroney sold 7,074 shares of Alignment Healthcare stock. The stock was sold at an average price of $9.02, for a total transaction of $63,807.48.

Alignment Healthcare Stock Performance

ALHC opened at $11.49 on Friday. The firm has a 50 day moving average of $11.59 and a two-hundred day moving average of $9.35. The firm has a market capitalization of $2.20 billion, a PE ratio of -14.92 and a beta of 1.45. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $14.25.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.14). Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The firm had revenue of $692.43 million during the quarter, compared to analysts’ expectations of $662.11 million. During the same quarter last year, the company posted ($0.19) earnings per share. The firm’s revenue was up 51.6% compared to the same quarter last year. On average, analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Institutional Trading of Alignment Healthcare

A number of hedge funds have recently modified their holdings of ALHC. Virtu Financial LLC purchased a new position in Alignment Healthcare during the first quarter valued at approximately $57,000. nVerses Capital LLC purchased a new position in shares of Alignment Healthcare during the 3rd quarter valued at approximately $95,000. Principal Financial Group Inc. lifted its stake in shares of Alignment Healthcare by 18.1% in the 2nd quarter. Principal Financial Group Inc. now owns 13,521 shares of the company’s stock valued at $106,000 after purchasing an additional 2,077 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Alignment Healthcare during the third quarter worth $131,000. Finally, Creative Planning grew its position in Alignment Healthcare by 20.0% during the third quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after buying an additional 2,072 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on ALHC shares. Barclays upped their price target on Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 30th. TD Cowen increased their price target on Alignment Healthcare from $8.00 to $10.00 and gave the company a “buy” rating in a research note on Tuesday, August 6th. Robert W. Baird boosted their price target on Alignment Healthcare from $10.00 to $11.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 14th. Piper Sandler reaffirmed an “overweight” rating and issued a $10.00 price objective (up from $8.00) on shares of Alignment Healthcare in a research report on Tuesday, August 6th. Finally, KeyCorp assumed coverage on shares of Alignment Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. One investment analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $10.33.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.